MBody AI (NASDAQ:MBAI) Stock Price Down 1.9% – Here’s What Happened

MBody AI Ltd. (NASDAQ:MBAI – Get Free Report)’s stock price traded down 1.9% during trading on Friday. The company traded as low as $2.05 and last traded at $2.05. 6,246 shares changed hands during mid-day trading, a decline of 75% from the average session volume of 24,602 shares. The stock had previously closed at $2.09.

Wall Street Analysts Forecast Growth

A number of equities research analysts have commented on MBAI shares. Zacks Research upgraded MBody AI to a “hold” rating in a research report on Tuesday, September 29th. Northland Securities began coverage on MBody AI in a report on Monday, September 28th. They set an “outperform” rating and a $10.00 price target for the company. One research analyst has rated the stock with a Buy rating and one has assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $10.00.

Read Our Latest Report on MBody AI

MBody AI Stock Down 1.9%

The business has a 50-day simple moving average of $3.64 and a 200-day simple moving average of $8.65. The company has a market cap of $2.82 million, a PE ratio of -0.28 and a beta of 0.74.

MBody AI Company Profile

(Get Free Report)

MBody AI, Inc. (NASDAQ:MBAI) is a technology company focused on applying artificial intelligence to health, wellness and body-composition management. Its business centers on developing digital tools intended to help users better understand and manage aspects of their fitness, nutrition and overall well-being. The company’s products and services are designed to use data-driven insights and personalized recommendations to support individual health and wellness goals. Publicly available information about MBody AI’s specific product portfolio, operating geographies and leadership team is limited.

Recommended Stories

Receive News & Ratings for MBody AI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MBody AI and related companies with MarketBeat.com's FREE daily email newsletter.